Adagio Therapeutics Inc (ADGI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2008 | 12-2007 | 12-2006 | 12-2005 | 12-2004 | |
| Sales | 144,424 | 38,603 | 87,015 | 112,222 | 146,201 |
| Cost of Goods | 123,969 | 41,245 | 81,097 | 94,154 | 105,819 |
| Gross Profit | 20,455 | -2,642 | 5,918 | 18,068 | 40,382 |
| Operating Expenses | 23,160 | 23,357 | 31,730 | 46,875 | 37,119 |
| Operating Income | -1,736 | -25,754 | -25,715 | -28,653 | 4,082 |
| Interest Expense | 6,403 | 10,878 | 8,884 | 2,568 | 2,441 |
| Other Income | -2,623 | -6,522 | 4,560 | -1,346 | 38 |
| Pre-tax Income | -10,762 | -43,154 | -30,039 | -32,567 | 1,679 |
| Income Tax | 214 | N/A | 11,340 | 1,060 | 309 |
| Net Income Continuous | -10,976 | -43,154 | -41,379 | -33,627 | 1,370 |
| Net Income Discontinuous | 534 | 21,876 | 282 | N/A | N/A |
| Net Income | $-10,442 | $-21,278 | $-41,097 | $-38,920 | $1,370 |
| EPS Basic Total Ops | -1.29 | -2.94 | -6.78 | -6.76 | 0.25 |
| EPS Basic Continuous Ops | -1.36 | -5.96 | -6.83 | -5.84 | 0.25 |
| EPS Basic Discontinuous Ops | 0.07 | 3.02 | 0.05 | N/A | N/A |
| EPS Diluted Total Ops | -1.29 | -2.94 | -6.78 | -6.76 | 0.24 |
| EPS Diluted Continuous Ops | -1.36 | -5.96 | -6.83 | -5.84 | 0.24 |
| EPS Diluted Discontinuous Ops | 0.07 | 3.02 | 0.05 | N/A | N/A |
| EBITDA(a) | $3,411 | $-17,084 | $-18,020 | $-19,291 | $8,812 |